Litigation Details for GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA (D. Del. 2014)
✉ Email this page to a colleague
GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA (D. Del. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-07-03 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:145 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | Judge Christopher J. Burke |
| Patents | RE40 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA
The small molecule drugs covered by the patent cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2016-04-12 | 110 | Amended Infringement Contentions for U.S. Patent No. RE40,000 Against Defendant Glenmark Pharmaceuticals… 3 July 2014 1:14-cv-00877-LPS-CJB Patent Plaintiff District Court, D. | External link to document | |
| 2016-06-03 | 133 | indirectly infringe U.S. Patent No. RE40,000 (the "'000 patent"). Presently before the…assignment, of the '000 patent, and GlaxoSmithKline LLC is the patent's exclusive licensee. (Id…, ex. B) Citation to the patent will simply be to the "'000 patent." … '000 Patent In June 1995, GSK and its research partner filed a patent application directed…CHF, which issued as U.S. Patent No. 5,760,069 (the '"069 patent") entitled "Method | External link to document | |
| 2016-09-19 | 159 | ., M.P.H. Regarding Infringement of U.S. Patent No. RE40,000 by Glenmark Pharmaceuticals, Inc. USA; (3… 3 July 2014 1:14-cv-00877-LPS-CJB Patent Plaintiff District Court, D. | External link to document | |
| 2017-02-17 | 251 | for disputed terms in U.S. Patent No. RE40,000 (the "'000 Patent"); WHEREAS, on…29) The Court agrees with Judge Burke that the patent uses the term "maintenance dose" to draw…patient's tolerance ofthis amount). Rather, the patent consistently uses 1 This term…term appears in all claims of the· '000 patent. …makes clear that the method claims Of the '000 patent cannot be practiced simply by "writing a | External link to document | |
| 2017-05-02 | 299 | United States Patent No. RE40,000 (the "Asserted Patent" or the '"000 patent"). Presently…069 patent, and on January 8, 2008, that patent reissued as the '000 patent. ('000 patent) In…CHF; the patent issued in June 1998 as U.S. Patent No. 5,760,069 (the "'069 patent"), entitled…60) If so, the patent claims a "new use" that is patentable; if not, the patent wrongly claims…the '000 patent claims were unknown in the prior art, the patent would claim a patentable new use of | External link to document | |
| 2014-07-03 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE40,000 E;. (dmp, ) (Main … 3 July 2014 1:14-cv-00877-LPS-CJB Patent Plaintiff District Court, D. | External link to document | |
| 2017-05-02 | 300 | Defendants induce infringement of United States Patent No. RE40,000 by making, offering to sell, selling, importing… MEMORANDUM ORDER In these two patent infringement actions filed by Plaintiffs GlaxoSmithKline… 3 In applying Rule 702 to a patent action, the Court will look to the law of the regional… 3 July 2014 1:14-cv-00877-LPS-CJB Patent Plaintiff District Court, D. | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
